Related references
Note: Only part of the references are listed.Big Data and paediatric cardiovascular disease in the era of transparency in healthcare
Alfred Asante-Korang et al.
CARDIOLOGY IN THE YOUNG (2017)
Ethical clinical translation of stem cell interventions for neurologic disease
David J. Cote et al.
NEUROLOGY (2017)
Hematopoietic Stem Cell Transplantation: A Bioethical Lens
Arcangelo Liso et al.
STEM CELLS INTERNATIONAL (2017)
Personalized Medicine and Adverse Drug Reactions: The Experience of An Italian Teaching Hospital
Raffaele La Russa et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2017)
Clinical Applications of Personalized Medicine: A New Paradigm and Challenge
Mariantonia Di Sanzo et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2017)
China's landscape in regenerative medicine
Xin Tang et al.
BIOMATERIALS (2017)
Incidental findings of uncertain significance: To know or not to know - that is not the question
Bjorn Hofmann
BMC MEDICAL ETHICS (2016)
Translation failure and medical reversal: Two sides to the same coin
Vinay Prasad
EUROPEAN JOURNAL OF CANCER (2016)
New ISSCR guidelines: clinical translation of stem cell research
Jonathan Kimmelman et al.
LANCET (2016)
Humanized organs in gene-edited animals
Mary G. Garry et al.
REGENERATIVE MEDICINE (2016)
Confronting stem cell hype
Timothy Caulfield et al.
SCIENCE (2016)
Promoting adverse drug reaction reporting: comparison of different approaches
Ines Ribeiro-Vaz et al.
REVISTA DE SAUDE PUBLICA (2016)
Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders
Kirstin R. W. Matthews et al.
BMC MEDICAL ETHICS (2015)
Regulating the therapeutic translation of regenerative medicine
Maude L. Cuchiara et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Regenerative medicine: Current therapies and future directions
Angelo S. Mao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The translation of cell-based therapies: clinical landscape and manufacturing challenges
Thomas R. J. Heathman et al.
REGENERATIVE MEDICINE (2015)
Stem cell hype: Media portrayal of therapy translation
Kalina Kamenova et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Ethical Considerations in Stem Cell Research on Neurologic and Orthopedic Conditions
John Dennis Banja
PM&R (2015)
From naive pluripotency to chimeras: a new ethical challenge?
Insoo Hyun
DEVELOPMENT (2015)
Creating human organs in chimaera pigs: an ethical source of immunocompatible organs?
David Shaw et al.
JOURNAL OF MEDICAL ETHICS (2015)
Human-Animal Chimera: A Neuro Driven Discussion? Comparison of Three Leading European Research Countries
Laura Yenisa Cabrera Trujillo et al.
SCIENCE AND ENGINEERING ETHICS (2015)
Biobanking human embryonic stem cell lines: policy, ethics and efficiency
Soren Holm
MONASH BIOETHICS REVIEW (2015)
Stem Cell Tourism and Public Education: The Missing Elements
Zubin Master et al.
CELL STEM CELL (2014)
Reducing waste from incomplete or unusable reports of biomedical research
Paul Glasziou et al.
LANCET (2014)
Taking a stand against pseudoscience
Elena Cattaneo et al.
NATURE (2014)
A Survey of Italian Physicians' Opinion about Stem Cells Research: What Doctors Prefer and What the Law Requires
Paola Frati et al.
BIOMED RESEARCH INTERNATIONAL (2014)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Stem cell therapy: from evidence-based medicine to emotion-based medicine? The long Italian way for a scientific regulation
Paola Frati et al.
STEM CELL RESEARCH & THERAPY (2013)
Please Don't Tell Me The Right Not to Know
Jonathan Herring et al.
CAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS (2012)
The Evolution of Policy Issues in Stem Cell Research: An International Survey
Timothy Caulfield et al.
STEM CELL REVIEWS AND REPORTS (2012)
Moving Human SCNT Research Forward Ethically
Insoo Hyun
CELL STEM CELL (2011)
Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes
Isabelle Boutron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Beyond Access vs. Protection in Trials of Innovative Therapies
Alex John London et al.
SCIENCE (2010)
Ethics in Egg Donation: Past, Present, and Future
Joshua U. Klein et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Stem cell banking: between traceability and identifiability
Bartha M. Knoppers et al.
GENOME MEDICINE (2010)
Governing stem cell banks and registries: Emerging Issues
Rosario M. Isasi et al.
STEM CELL RESEARCH (2009)
Monetary payments for the procurement of oocytes for stem cell research: In search of ethical and political consistency
Rosario M. Isasi et al.
STEM CELL RESEARCH (2007)
The right not to know: an autonomy based approach
R Andorno
JOURNAL OF MEDICAL ETHICS (2004)
Association of funding and conclusions in randomized drug trials - A reflection of treatment effect or adverse events?
B Als-Nielsen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Prospects for stem cell therapeutics: myths and medicines
GQ Daley
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Share Paper
